参考文献/References:
[1] Grotta J C,Welch K M,Fagan S C,et al.Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial[J]. Stroke,2001,32(3):661-668. [2] Zinkstok S M,Roos Y B.Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke:a randomised controlled trial[J].The Lancet,2012,380(9843): 731-737. [3] Ibrahim M M,Sebastian J,Hussain M,et al. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke [J].Cerebrovascular Diseases,2010,30(5):508-513. [4] ?aňák D, Kuliha M,Herzig R,et al.Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis [J].European neurology,2012,67(1):52-56. [5] Diedler J,Ahmed N,Sykora M,et al.Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset[J].Stroke,2010,41(2): 288-294. [6] Adams H P,Del Zoppo G,Alberts M J,et al.Guidelines for the early management of adults with ischemic stroke[J]. Circulation,2007,15(20):e478-e534. [7] Prabhakaran S,Rivolta J,Vieira J R,et al.Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke[J].Archives of neurology,2010, 67(5):559-563. [8] Barreto A D,Ford G A,Shen L,et al.Randomized, multicenter trial of ARTSS-2(argatroban with recombinant tissue plasminogen Activator for Acute Stroke)[J].Stroke, 2017,48(6):1608-1616. [9] Chan P H.Reactive oxygen radicals in signaling and damage in the ischemic brain[J].Journal of Cerebral Blood Flow & Metabolism,2001,21(1):2-14. [10] Maier C M,Hsieh L,Crandall T,et al.Evaluating therapeutic targets for reperfusion-related brain hemorrhage[J].Annals of neurology,2006,59(6):929-938. [11] Lee B J,Egi Y,van Leyen K,et al.Edaravone,a free radical scavenger,protects components of the neurovascular unit against oxidative stress in vitro[J].Brain research,2010, 1307:22-27. [12] Kano T,Harada T,Katayama Y.Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger,edaravone: evaluation in a rat thromboembolic stroke model[J].Neurological research,2005,27(5):499-502. [13] Yamashita T,Kamiya T,Deguchi K,et al.Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain[J].Journal of Cerebral Blood Flow & Metabolism,2009,29(4):715-725. [14] Kimura K,Aoki J,Sakamoto Y,et al.Administration of edaravone,a free radical scavenger,during t-PA infusion can enhance early recanalization in acute stroke patients-a preliminary study[J].Journal of the neurological sciences, 2012,313(1):132-136. [15] Endres M.Statins and stroke[J].Journal of Cerebral Blood Flow & Metabolism:Official Journal of the International Society of Cerebral Blood Flow & Metabolism,2005,25(9): 1093-1110. [16] Laufs U,Gertz K, Huang P,et al.Atorvastatin upregulates type III nitric oxide synthase in thrombocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31(10):2442-2449. [17] Liu X S,Zhang Z G,Zhang L,et al.Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating - 89 - coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection[J]. Journal of Cerebral Blood Flow & Metabolism,2006,26(6): 787-796. [18] Stüve O,Youssef S,Steinman L,et al.Statins as potential therapeutic agents in neuroinflammatory disorders[J]. Current opinion in neurology,2003,16(3):393-401. [19] Zhang L,Zhang Z G,Ding G L,et al.Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat[J].Circulation,2005,112(22):3486-3494. [20] Koh K K,Son J W,Ahn J Y,et al.Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease[J].Arteriosclerosis Thrombosis & Vascular biology, 2002,22(9):e19-e23. [21] Zhang L,Chopp M,Jia L,et al.Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats[J].Journal of cerebral blood flow & metabolism,2009,29(11):1816-1824. [22] Montaner J,Alvarez-Sabin J,Molina CA,et al.Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke[J].Stroke,2001; 32:2762-2767. [23] Adibhatla R M,Hatcher J F.Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke:therapeutic strategies[J].CNS & Neurological Disorders- Drug Targets,2008,7(3):243-253. [24] Machado L S,Sazonova I Y,Kozak A,et al.Minocycline and tissue-type plasminogen activator for stroke[J].Stroke, 2009,40(9):3028-3033. [25] Rosenberg GA,Yang Y.Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia[J].Neurosurgical focus,2007,22(5):1-9. [26] Zhao B Q,Wang S,Hahn-Young K I M,et al.Role of matrix metalloproteinases in delayed cortical responses after stroke[J].Nature Medicine,2006,12(4):441-445. [27] Sumii T,Lo E H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats[J].Stroke,2002,33(3):831- 836. [28] Yenari M A,Xu L,Tang X N,et al.Microglia potentiate damage to blood–brain barrier constituents[J].Stroke, 2006,37(4):1087-1093. [29] Sutton T A,Kelly K J,Mang H E,et al.Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury[J].American Journal of Physiology-Renal Physiology, 2005,288(1):F91-F97. [30] Murata Y,Rosell A,Scannevin R H,et al.Extension of the thrombolytic time window with minocycline in experimental stroke[J].Stroke,2008,39(12):3372-3377. [31] Polavarapu R,Gongora M C,Yi H,et al.Tissue-type plasminogen activator–mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit[J].Blood,2007, 109(8):3270-3278. [32] Zhao B Q,Tejima E,Lo E H.Neurovascular proteases in brain injury,hemorrhage and remodeling after stroke[J].Stroke, 2007,38(2):748-752. [33] Yepes M,Sandkvist M,Wong M K K,et al.Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis[J].Blood,2000,96(2):569-576. [34] 陈立云,曾进胜,李常新,等.rt-PA 应用后 MMP-2,MMP-9表达的改变及Neuroserpin 的影响[J].中国神经精神疾病杂志,2003,29(4):258-261. [35] 江涛,刘金民,方晓磊.中医药干预急性脑梗死溶栓疗效的 Meta 分析[J].中医药临床杂志,2006,18(4):328-330.